Wealth Enhancement Advisory Services’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Sell |
174,006
-60,065
| -26% | -$75.7K | ﹤0.01% | 2888 |
|
|
2025
Q1 | $372K | Buy |
234,071
+33,958
| +17% | +$54K | ﹤0.01% | 2252 |
|
|
2024
Q4 | $606K | Buy |
200,113
+132,220
| +195% | +$401K | ﹤0.01% | 1826 |
|
|
2024
Q3 | $250K | Buy |
67,893
+20,848
| +44% | +$76.7K | ﹤0.01% | 2284 |
|
|
2024
Q2 | $192K | Buy |
47,045
+3,870
| +9% | +$15.8K | ﹤0.01% | 2303 |
|
|
2024
Q1 | $680K | Buy |
+43,175
| New | +$680K | ﹤0.01% | 1411 |
|